Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

DCTH Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.94%

Insider Buying (Last 12 Months): $199,961.04

Insider Selling (Last 12 Months): $0.00

Delcath Systems Insider Trading History Chart

Delcath Systems Share Price & Price History

^$9.81

▲ +0.18 (1.87%)

As of 11/21/2024 01:50 PM ET

Days: 30 | 90 | 365

Trump won. Buy this coin now.

From Weiss Ratings | Ad

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

This could be his favorite coin.

Delcath Systems Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/19/2024	Gil Aharon	Director	Buy	26,882	$3.72	$100,001.04	1,069,710
12/8/2023	Gerard J. Michel	CEO	Buy	34,000	$2.94	$99,960.00	262,345
11/17/2023	Rosalind Advisors, Inc.	Director	Buy	100,000	$2.40	$240,000.00	1,038,828
11/17/2023	Sandra Pennell	SVP	Buy	30,000	$2.43	$72,900.00	30,000
11/16/2023	Vojo Vukovic	Insider	Buy	60,000	$2.48	$148,800.00	60,000
10/13/2023	John Purpura	COO	Buy	14,505	$3.44	$49,897.20	41,526
8/21/2023	John Richard Sylvester	Director	Buy	10,550	$4.80	$50,640.00	10,550
3/29/2023	Gerard J. Michel	CEO	Buy	19,646	$4.84	$95,086.64	197,235
12/14/2022	Rosalind Advisors, Inc.	Director	Buy	15,215	$3.62	$55,078.30	459,315
7/20/2022	Gerard J. Michel	CEO	Buy	62,814	$3.98	$249,999.72	125,864
5/16/2022	John Purpura	COO	Buy	3,300	$4.61	$15,213.00	27,021
5/12/2022	Steven A. J. Salamon	Director	Buy	6,000	$4.90	$29,400.00	29,424
4/19/2022	Steven A. J. Salamon	Director	Buy	1,600	$6.25	$10,000.00	429,100
4/18/2022	Gerard J. Michel	Insider	Buy	2,000	$6.37	$12,740.00	63,050
4/12/2022	Rosalind Advisors, Inc.	Director	Buy	2,500	$6.48	$16,200.00	428,000
4/11/2022	John Purpura	COO	Buy	5,000	$6.59	$32,950.00	23,721
4/8/2022	Gerard J. Michel	Insider	Buy	2,000	$6.57	$13,140.00	61,050
4/6/2022	Rosalind Advisors, Inc.	Director	Buy	1,000	$6.49	$6,490.00
12/2/2021	Gerard J. Michel	Insider	Buy	23,200	$8.61	$199,752.00

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Delcath Systems (NASDAQ:DCTH)

61.12% of Delcath Systems stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Delcath Systems Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Virtu Financial LLC	32,000	$0.29M	0.0%	N/A	0.100%
11/19/2024	Barclays PLC	11,479	$0.10M	0.0%	N/A	0.036%
11/16/2024	Geode Capital Management LLC	251,895	$2.28M	0.0%	+3.0%	0.788%
11/15/2024	Barclays PLC	11,479	$0.10M	0.0%	N/A	0.036%
11/15/2024	Jane Street Group LLC	12,208	$0.11M	0.0%	N/A	0.038%
11/15/2024	State Street Corp	85,457	$0.77M	0.0%	+12.4%	0.267%
11/15/2024	Polar Asset Management Partners Inc.	176,500	$1.59M	0.0%	N/A	0.552%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	11,318	$0.10M	0.0%	N/A	0.035%
11/14/2024	Verition Fund Management LLC	17,382	$0.16M	0.0%	-20.4%	0.054%
10/31/2024	Principal Financial Group Inc.	89,447	$0.81M	0.0%	N/A	0.322%
10/23/2024	Riverwater Partners LLC	18,628	$0.16M	0.1%	N/A	0.067%
9/16/2024	Cubist Systematic Strategies LLC	44,222	$0.37M	0.0%	N/A	0.159%
8/15/2024	Shellback Capital LP	161,688	$1.35M	0.1%	N/A	0.582%
8/14/2024	Cubist Systematic Strategies LLC	44,222	$0.37M	0.0%	N/A	0.159%
8/14/2024	Marshall Wace LLP	92,731	$0.78M	0.0%	+7.0%	0.334%
8/9/2024	Renaissance Technologies LLC	82,900	$0.69M	0.0%	N/A	0.298%
8/7/2024	Levin Capital Strategies L.P.	15,000	$0.13M	0.0%	-72.7%	0.054%
8/7/2024	AIGH Capital Management LLC	2,399,792	$20.09M	6.2%	+1.7%	8.637%
7/26/2024	Legato Capital Management LLC	115,463	$0.97M	0.1%	N/A	0.415%
7/12/2024	Rosalind Advisors Inc.	2,650,389	$22.18M	16.2%	+155.1%	9.537%
5/16/2024	Levin Capital Strategies L.P.	54,969	$0.26M	0.0%	+12.2%	0.198%
5/16/2024	BVF Inc. IL	1,202,067	$5.73M	0.2%	+23.1%	4.327%
5/10/2024	Vanguard Group Inc.	683,686	$3.26M	0.0%	+31.0%	2.461%
4/22/2024	Vivo Capital LLC	1,666,746	$7.95M	0.6%	+94.9%	6.552%
2/14/2024	ADAR1 Capital Management LLC	231,302	$0.96M	0.3%	N/A	1.049%
2/12/2024	AIGH Capital Management LLC	1,182,198	$4.92M	2.0%	N/A	5.361%
2/9/2024	Worth Venture Partners LLC	294,248	$1.22M	0.7%	N/A	1.334%
2/7/2024	Vivo Capital LLC	855,191	$3.56M	0.3%	-53.9%	3.878%
2/6/2024	Levin Capital Strategies L.P.	49,000	$0.20M	0.0%	+22.5%	0.222%
1/5/2024	WealthPlan Investment Management LLC	17,443	$73K	0.0%	N/A	0.079%
11/15/2023	Kent Lake Capital LLC	125,000	$0.51M	0.2%	-43.0%	0.818%
11/15/2023	Armistice Capital LLC	164,000	$0.66M	0.0%	N/A	1.074%
11/14/2023	Stonepine Capital Management LLC	686,240	$2.78M	0.9%	+81.2%	4.491%
11/8/2023	Vivo Capital LLC	1,855,191	$7.51M	0.9%	+57.4%	12.141%
10/31/2023	Levin Capital Strategies L.P.	40,000	$0.16M	0.0%	N/A	0.262%
8/16/2023	Stonepine Capital Management LLC	378,787	$2.10M	0.8%	N/A	3.567%
8/15/2023	BVF Inc. IL	1,178,787	$6.87M	0.2%	N/A	11.100%
8/11/2023	Cibc World Market Inc.	124,717	$0.73M	0.0%	+21.3%	1.174%
7/27/2023	Virtu Financial LLC	10,921	$64K	0.0%	N/A	0.103%
5/4/2023	Advisors Capital Management LLC	27,021	$0.16M	0.0%	N/A	0.269%
8/10/2022	Cibc World Market Inc.	83,751	$0.33M	0.0%	-5.6%	1.059%
5/12/2022	CI Investments Inc.	87,367	$0.56M	0.0%	N/A	1.105%
2/15/2022	CIBC World Markets Inc.	85,319	$0.66M	0.0%	N/A	1.160%
11/16/2021	Schonfeld Strategic Advisors LLC	81,600	$0.85M	0.0%	-6.0%	1.109%
11/9/2021	BlackRock Inc.	13,794	$0.14M	0.0%	-11.6%	0.187%
8/16/2021	Squarepoint Ops LLC	24,773	$0.31M	0.0%	+90.6%	0.337%
8/16/2021	Schonfeld Strategic Advisors LLC	86,800	$1.10M	0.0%	-20.5%	1.180%
8/13/2021	Northern Trust Corp	12,743	$0.16M	0.0%	N/A	0.173%
8/13/2021	Geode Capital Management LLC	58,722	$0.74M	0.0%	+46.6%	0.836%
8/12/2021	Advisory Services Network LLC	3,150	$40K	0.0%	N/A	0.045%
5/18/2021	Alyeska Investment Group L.P.	36,148	$0.45M	0.0%	-27.1%	0.559%
5/18/2021	Silverarc Capital Management LLC	40,000	$0.50M	0.3%	-88.6%	0.618%
5/17/2021	Schonfeld Strategic Advisors LLC	109,235	$1.36M	0.0%	N/A	1.688%
5/17/2021	Ikarian Capital LLC	43,915	$0.55M	0.0%	-61.0%	0.679%
5/17/2021	Goldman Sachs Group Inc.	10,097	$0.13M	0.0%	N/A	0.156%
5/13/2021	Renaissance Technologies LLC	15,900	$0.20M	0.0%	-84.3%	0.254%
5/12/2021	Geode Capital Management LLC	40,044	$0.50M	0.0%	+50.7%	0.641%
5/12/2021	MYDA Advisors LLC	20,000	$0.25M	0.1%	N/A	0.320%
2/24/2021	Alyeska Investment Group L.P.	49,603	$0.89M	0.0%	N/A	1.205%
2/18/2021	Verition Fund Management LLC	30,000	$0.54M	0.0%	N/A	0.729%
2/16/2021	Silverarc Capital Management LLC	351,616	$6.30M	3.7%	N/A	8.541%
2/16/2021	Squarepoint Ops LLC	13,563	$0.24M	0.0%	-45.6%	0.329%
2/16/2021	Alyeska Investment Group L.P.	49,603	$0.89M	0.0%	N/A	1.205%
2/16/2021	Pura Vida Investments LLC	65,000	$1.17M	0.0%	N/A	1.579%
2/12/2021	AWM Investment Company Inc.	87,000	$1.56M	0.2%	N/A	2.113%
2/12/2021	Ikarian Capital LLC	112,712	$2.02M	0.1%	+19.9%	2.738%
2/10/2021	Renaissance Technologies LLC	101,276	$1.82M	0.0%	N/A	2.460%
11/16/2020	Squarepoint Ops LLC	24,931	$0.29M	0.0%	+43.9%	0.610%
11/16/2020	Worth Venture Partners LLC	22,598	$0.26M	0.2%	-11.4%	0.553%
11/13/2020	Morgan Stanley	6,084	$71K	0.0%	+608,300.0%	0.149%

Data available starting January 2016

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Today's Range

Now: $9.81

$9.59

$9.98

50 Day Range

MA: $9.68

$8.18

$11.37

52 Week Range

Now: $9.81

$2.60

$12.88

Volume

164,494 shs

Average Volume

277,923 shs

Market Capitalization

$313.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.75

Who are the company insiders with the largest holdings of Delcath Systems?: Delcath Systems' top insider shareholders include:
Gil Aharon (Director)
Rosalind Advisors, Inc (Director)
Gerard J Michel (CEO)
Vojo Vukovic (Insider)
John Purpura (COO)
Sandra Pennell (SVP)
John Richard Sylvester (Director)
Learn More about top insider investors at Delcath Systems.
Who are the major institutional investors of Delcath Systems?: Delcath Systems' top institutional shareholders include:
Geode Capital Management LLC — 0.79%
Polar Asset Management Partners Inc. — 0.55%
Principal Financial Group Inc. — 0.32%
State Street Corp — 0.27%
Virtu Financial LLC — 0.10%
Riverwater Partners LLC — 0.07%
Learn More about top institutional investors of Delcath Systems stock.
Which major investors are selling Delcath Systems stock?: In the last quarter, DCTH stock was sold by these institutional investors:
Wolverine Trading LLC
Verition Fund Management LLC
Which major investors are buying Delcath Systems stock?: During the last quarter, DCTH stock was purchased by institutional investors including:
Polar Asset Management Partners Inc.
Principal Financial Group Inc.
Virtu Financial LLC
Riverwater Partners LLC
Jane Street Group LLC
Barclays PLC
Barclays PLC
Point72 Asia Singapore Pte. Ltd.
Within the last year, these company insiders have bought Delcath Systems stock:
Gil Aharon (Director)
Rosalind Advisors, Inc (Director)
Gerard J Michel (CEO)
Vojo Vukovic (Insider)
John Purpura (COO)
Sandra Pennell (SVP)
John Richard Sylvester (Director)
Learn More investors buying Delcath Systems stock.

This company will win the AI race